Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Recurrence of disease activity after repeated Natalizumab withdrawals.
The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis.
Recent Gains in Clinical Multiple Sclerosis Research Review.
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.
Immunopathology of multiple sclerosis.
Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases.
Data at AAN showed Gilenya® high efficacy in achieving 'no evidence of disease activity' in previously-treated highly-active MS patients
Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis.
Does glatiramer acetate provoke hepatitis in multiple sclerosis?
Systematic approaches to central nervous system myelin.
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Birth outcomes of pregnancies fathered by men with multiple sclerosis.
Multiple sclerosis: a primary care perspective.
Association of IL4 and IL4R polymorphisms with multiple sclerosis susceptibility in Caucasian population: A meta-analysis.
Zebrafish screen identifies novel compound with selective toxicity against leukemia.
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease.
Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in sweden.
Functional role of TRP channels in modulating ER stress and Autophagy.
[Cyclophosphamide pulse therapy effective for childhood-onset refractory multiple sclerosis: a case report].
Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open-label study.
Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study.

Pages